(C) Wolf G Kroner 2010 - mass spectrometric dataHandling Suppliers of Mass Spectrometers Delicately

July 2010. Manufacturers of mass spectrometers have comprehensible reasons to capture buyers, but initiatives to create uniform standards across instrumentation platforms are lacking continuity and disinterest, says proteomics researcher Michael Myers, Group Leader, Protein Networks at the International Centre for Genetic Engineering and Biotechnology, Trieste (IT). Notwithstanding users of mass spectrometers are not thrown upon suppliers’ mercy.


If you like to read this article, you can purchase it now

Please notice, when purchasing articles you agree to B2Bioworld's Terms and Conditions

Read Now - Please select your license (Prices incl. 7% VAT)

Article free of advertisement - 2 pages

Full Company License enquire here

Back to section

Related Editorial Articles

Diagnostic Microfluidics: Sample In – Results Out?
Marc Feiglin, former Chief Technology Officer Life Sciences at Tecan on strengths and weaknesses of electrowetting development, weaknesses of competitors like Illumina. Prospects of clinical microfluidics

Laboratory Automation: Everyone Re-invents The Wheel
Michael Collasius, Vice President Automated Systems Qiagen NV, on industry-wide standards for laboratory instruments

Custom Sequencing Markets
Worldwide evolution of the market and upcoming business opportunities

Electrophoresis in Proteomics
– Some Common Pitfalls and Smart Ways to Avoid Them

Instrument Standards: We need the users, and users have to adopt it
A Global View on Interconnectivity, Quality, Harmonisation of Standards of Laboratory Automation and Biomanufacturing by Oscar-Werner Reif, Member of Board Sartorius Stedim Biotech S.A.

Thermo Fisher’s BRIMS-Strategy Under Testing

Metrics for Disease, Health, and Wellness
A systems look at DNA sequencing for personalized medicine by Dr Leroy Hood, President Institute for Systems Biology, Seattle